A share price of Edwards Lifesciences Corp [EW] is currently trading at $86.29, up 0.07%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The EW shares have gain 1.71% over the last week, with a monthly amount glided 1.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Edwards Lifesciences Corp [NYSE: EW] stock has seen the most recent analyst activity on December 18, 2025, when JP Morgan upgraded its rating to an Overweight but kept the price target unchanged to $100 for it. Previously, Raymond James upgraded its rating to Outperform on November 03, 2025, and kept the price target unchanged to $96. On October 29, 2025, upgrade upgraded it’s rating to Peer Perform. Jefferies upgraded its rating to a Buy but stick to its price target of $98 on October 29, 2025. Oppenheimer downgraded its rating to a Perform. Evercore ISI upgraded its rating to Outperform for this stock on October 07, 2025, but kept the price target unchanged to $88. In a note dated July 29, 2025, BTIG Research upgraded a Buy rating on this stock but restated the target price of $100.
Edwards Lifesciences Corp experienced fluctuations in its stock price throughout the past year between $65.94 and $87.89. Currently, Wall Street analysts expect the stock to reach $95.47 within the next 12 months. Edwards Lifesciences Corp [NYSE: EW] shares were valued at $86.29 at the most recent close of the market. An investor can expect a potential return of 10.64% based on the average EW price forecast.
Analyzing the EW fundamentals
Trailing Twelve Months sales for Edwards Lifesciences Corp [NYSE:EW] were 5.88B which represents 14.67% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.27%, Pretax Profit Margin comes in at 0.27%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.13 and Total Capital is 0.13. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.89 points at the first support level, and at 85.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 86.60, and for the 2nd resistance point, it is at 86.90.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Edwards Lifesciences Corp [NYSE:EW] is 4.00. Further, the Quick Ratio stands at 3.29, while the Cash Ratio is 1.69. Considering the valuation of this stock, the price to sales ratio is 8.51, the price to book ratio is 4.91 and price to earnings (TTM) ratio is 36.73.
Transactions by insiders
Recent insider trading involved BOBO DONALD E JR, CVP,Strategy/Corp Development, that happened on Dec 12 ’25 when 11386.0 shares were sold. CVP, JAPAC, Lippis Daniel J. completed a deal on Dec 12 ’25 to sell 1019.0 shares. Meanwhile, Director STONE HEISZ LESLIE sold 2615.0 shares on Dec 12 ’25.
